6 completed. 6 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 6 | Completed 6 |
Follow Cold Urticaria: new trials by email Literature Review of Cold Urticaria trials Research Report on Cold Urticaria
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study to Evaluate the Safety, Tolerability, Efficacy and Pharmacokinetics of JTE-162 in Subjects With Cryopyrin-Associated Periodic Syndrome (CAPS) JTE-162 - Cryopyrin-associated Periodic Syndromes (CAPS) | Phase 1 | Completed | Akros Pharma Inc. | 5 | 2026-02-02 | 2026-10-09 |
| A Single Dose, Phase 1 Study of YH35324 in Patients with Various Allergic Diseases YH35324, Omalizumab, Placebo - Allergic Disease, Chronic Spontaneous Urticaria | Phase 1 | Completed | Yuhan Corporation | 30 | 2023-08-23 | 2024-11-22 |
| A Single Dose Study of the Safety, Pharmacokinetics and Pharmacodynamics of CDX-0159 in Patients With Cold Contact Urticaria, Symptomatic Dermographism, or Cholinergic Urticaria CDX-0159 - Cold Urticaria, Cold Contact Urticaria | Phase 1 | Completed | Celldex Therapeutics | 41 | 2020-11-24 | 2023-05-17 |
| Safety and Tolerability, Pharmacokinetic and Pharmacodynamic Study With IZD334 IZD334, Placebos - Healthy Volunteers, Cryopyrin Associated Periodic Syndrome | Phase 1 | Completed | Inflazome UK Ltd | 64 | 2019-09-13 | 2020-03-02 |
| A Dose-Block Randomized, Placebo Controlled (Double-blind), Active Controlled(Open-label), Dose-escalation Study HL2351, Kineret(Anakinra) - Healthy Volunteers | Phase 1 | Completed | Handok Inc. | 58 | 2014-05-01 | 2015-10-06 |
| The Use of Kineret (Anakinra) in the Treatment of Familial Cold Urticaria Kineret (anakinra) - Familial Cold Urticaria | Phase 1 | Completed | Nova Scotia Health Authority | 8 | 2005-09-01 | 2022-11-08 |
Cryopyrin-Associated Periodic Syndromes (4) · Arthritis, Rheumatoid (1) · Chronic Inducible Urticaria (1) · Chronic Urticaria (1) · Familial dermographism (1)
Hypersensitivity (6) · Hypersensitivity, Immediate (6) · Immune System Diseases (6) · Skin Diseases (6) · Skin Diseases, Vascular (6) · Skin and Connective Tissue Diseases (6) · Urticaria (6) · Chronic Disease (5) · Disease Attributes (5) · Pathologic Processes (5) · Pathological Conditions, Signs and Symptoms (5) · Chronic Inducible Urticaria (4) · Chronic Urticaria (4) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (4)
Interleukin 1 Receptor Antagonist Protein (2) · Injections (1) · Omalizumab (1)
Akros Pharma Inc. (1) · Celldex Therapeutics (1) · Handok Inc. (1) · Inflazome UK Ltd (1) · Nova Scotia Health Authority (1) · Yuhan Corporation (1)
Canada (2) · South Korea (2) · Australia (1) · Germany (1)
Hae-Sim Park (1) · Hyeong Ki Lee, Professor (1) · Jason Lickliter, MBBS, PhD (1)